Ethical disclosure of biomarkers for Alzheimer risk in Latin American participants
We discuss strategies to support responsible disclosure practices, including culturally sensitive participant education, enhanced provider training, and policy adaptations to improve accessibility and support systems. Ultimately, we advocate for a careful, context-specific approach to AD biomarker disclosure that prioritizes patient well-being and equity in low-resource environments.
Authors
- Adam E. Tratner (ORCID: https://orcid.org/0000-0003-2439-4289)
- Diana C. Oviedo (ORCID: https://orcid.org/0000-0003-1987-5205)
- Alcibiades E. Villarreal (ORCID: https://orcid.org/0000-0002-6684-0593)
- Casey D. Xavier Hall (ORCID: https://orcid.org/0000-0003-1658-3717)
- Sherelle L. Harmon (ORCID: https://orcid.org/0000-0002-7727-6908)
- María B. Carreira (ORCID: https://orcid.org/0000-0001-5306-0021)
- Eugenia Millender (ORCID: https://orcid.org/0000-0003-3042-9046)
- Rasheda Haughbrook (ORCID: https://orcid.org/0000-0001-5837-6009)
- Zhuo Meng
- Gabrielle B. Britton (ORCID: https://orcid.org/0000-0002-1758-2495)
- Carli Culjat
- Ladanya Ramirez Surmeier
- Oriana I. Batista
Institutions
- Florida State University (US)
- Universidad de Panamá (PA)
- Florida State University-Panama (PA)
- Florida A&M University - Florida State University College of Engineering (US)
- Universidad Autónoma de Chiriquí (PA)
- Universidad Católica Santa María La Antigua (PA)
- Secretaría Nacional de Ciencia, Tecnología e Innovación (PA)
- Empowerment Program (US)
- Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (PA)
Publication Details
- Journal
- Frontiers in Dementia
- Published
- 2025-10-28
- DOI
- https://doi.org/10.3389/frdem.2025.1672075
- Citations
- 1
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Secretaria Nacional de Ciencia y Tecnología
- National Institutes of Health
- National Heart, Lung, and Blood Institute